Christopher Lindop, CFO & EVP Business Development at Haemonetics, holds 376.65K shares in Quotient (Ticker: QTNTQ), holds 20.25K shares in Parexel (Ticker: PRXL), holds 56.74K shares in Haemonetics (Ticker: HAE).

See the Hottest Stocks Based on Insider Trading >

Christopher Lindop
Haemonetics (HAE)
CFO & EVP Business Development

Ranked #54,051 out of 98,909 Corporate Insiders

Profitable Transactions

3 out of 6 Profitable Transactions

Average Return

-2.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

HAE

A breakdown of Christopher Lindop's holdings

See the Top Stocks by Insiders

Insider Roles

Haemonetics
(HAE)

CFO & EVP Business Development

Roles that Christopher Lindop holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Quotient
(QTNTQ)

Rating:Informative Buy

Date:Jul 19, 2018 - Jul 19, 2019

Return:+35.30%

The most profitable trade made by Christopher Lindop

See the Latest Stocks Traded by Insiders

Christopher Lindop's Trading History

HAE

Haemonetics

Jan 19, 2016

CFO & EVP Business Development

Uninformative Buy

113.93

$5.53M

QTNTQ

Quotient

May 26, 2020

―

Uninformative Buy

―

$14.69K

PRXL

Parexel

Oct 04, 2017

―

Uninformative Sell

―

$1.78M

~ALR

Alere Inc

―

$0.00

List of latest transactions for each holding click on a transaction to see Christopher Lindop's performance on stock

See All Insider Trading from Today

Christopher Lindop insider profile FAQ

What is the percentage of profitable transactions made by Christopher Lindop?

The percentage of profitable transactions made by Christopher Lindop is 50%.

What is the average return per transaction made by Christopher Lindop?

The average return per transaction made by Christopher Lindop is -2.10%.

What stocks does Christopher Lindop hold?

Christopher Lindop holds: HAE, QTNTQ, PRXL, ~ALR stocks.

What was Christopher Lindop’s latest transaction?

Christopher Lindop latest transaction was an Uninformative Buy of ―.

What was Christopher Lindop's most profitable transaction?

Christopher Lindop’s most profitable transaction was an Informative Buy of QTNTQ stock on July 19, 2018. The return on the trade was 35.30%.

What is Christopher Lindop's role in Haemonetics?

Christopher Lindop's role in Haemonetics is CFO & EVP Business Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Christopher Lindop Insider Profile

Christopher Lindop Haemonetics (HAE)CFO & EVP Business Development